Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Aug 31;216(9):1141–1149. doi: 10.1093/infdis/jix450

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America.

This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

PMC Copyright notice

Figure 2. — Projected impact of point-of-care (POC) tests on gonorrhea prevalence and resistance. Population prevalence and prevalence of different strains are shown in the face of (A) no POC testing, (B and E) 10%, (C and F) 25%, and (D and G) 50% of cases tested. B–D show the results for a POC test for resistance to antibiotic A only. E–G show results for a POC test for resistance to all 3 antibiotics. For the 3-resistance POC test, cases undergoing testing and displaying susceptibility to >1 antibiotic were treated with the antibiotic with the highest fitness cost associated with resistance acquisition. For both scenarios, all untested cases were treated in combination with antibiotics B and C. Results are shown for tests with perfect sensitivity and specificity.